http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015176054-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bd7a45a343acd10e3f5d8775dda2157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8e76c5c39dc5cf119c469ab70208429
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02E50-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-13
filingDate 2015-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44783c864ed0e5a50a72a5d410c5205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8698f397d921d026c9c96e0d7506bea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c6ba7114d975cee7d89565a3c0d9a8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cdc76f97691812998d93e5676175eb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d5795ae32ba20ff25de1c004b9b4889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7091f1b0160a838325c5dfbc815af135
publicationDate 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015176054-A3
titleOfInvention Recombinant polynucleotide sequence for producing astaxanthin and uses thereof
abstract Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.
priorityDate 2014-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008133658-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013098819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011146833-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2199399-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004091958-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5368397

Total number of triples: 34.